Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HyperStem is an Italian biotechnology company specializing in regenerative medicine through the optimization of mesenchymal stem cells (MSCs). The company utilizes its proprietary HyperStem technology, which involves hyperbaric conditioning to enhance the therapeutic potency, proliferation, and secretome profile of stem cells. Their primary focus is on developing advanced therapies for wound healing, skin regeneration, and inflammatory conditions. By leveraging the enhanced regenerative properties of conditioned MSCs and their exosomes, HyperStem aims to provide more effective treatments for chronic and complex pathologies. The company's approach integrates bioengineering with cell biology to create standardized, high-potency cellular products suitable for clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HyperStem.